FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $1,594 | +59% |
| 3 years ago (2023) | $2,493 | +149% |
| 5 years ago (2021) | $3,805 | +280% |
| 10 years ago (2016) | $17,736 | +1674% |
| since 2016 | $17,736 | +1674% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | -6% | $943 (-6%) |
| 2025 | +69% | $1,594 (+59%) |
| 2024 | +8% | $1,728 (+73%) |
| 2023 | +44% | $2,493 (+149%) |
| 2022 | -2% | $2,433 (+143%) |
| 2021 | +56% | $3,805 (+280%) |
| 2020 | +66% | $6,300 (+530%) |
| 2019 | +59% | $10,005 (+901%) |
| 2018 | +46% | $14,605 (+1361%) |
| 2017 | +1% | $14,682 (+1368%) |
π See the analyst analysis of Medpace β
$1000 invested in Medpace 5 years ago would be worth $3,805 today, and $17,736 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: +8%. 2025: +69%. 2026: -6%. Full breakdown in the table above.
Over 10 years, Medpace's average annual return (CAGR) is about 33% per year, and 31%/yr over 5 years.
Best year: 2025 (+69%). Worst year: 2022 (-2%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Medpace is worth $3,805, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.